净利润大增34.9%,三生制药转身

牛刀财经
31 Mar

文丨胡戈美编丨李成蹊出品丨牛刀财经(niudaocaijing)近期,三生制药(01530.HK)发布截至2024年12月31日止年度业绩,公司全年实现收入91.08亿元,同比增长6.53%;归母净利润20.9亿元,同比增长34.93%;经调整的经营性归母净利润约23.18 亿元,同比增长18.8%。董事会建议宣派末期股息每股25港仙。需要注意的是,2019年以来三生制药净利润表现为较大波动,且...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10